Retatrutide side effects reported so far are mainly gastrointestinal, including nausea, vomiting, diarrhea, constipation, and reduced appetite
This becomes especially important when you're in a calorie deficit and using GLP-1 therapy, as appetite suppression can sometimes make it harder to eat enough protein
Fluorescence images were acquired with BX50 microscope and DP50 digital camera (Olympus, Tokyo, Japan)
Recommendations for Managing Medication Interactions To minimize adverse interactions between semaglutide and other medications: Consult Healthcare Providers: Patients should inform their doctors about all medications they are currently taking, including supplements and over-the-counter drugs
When Biomarkers and Genetics May Influence Your Treatment Continuity Your genetic predispositions in peptide pathwaysrevealed by PlexusDx's Precision Peptide Genetic Testmay inform how your provider evaluates your individual response pattern over time
Weekly doses ranged from 0.5 to 7.2 mg for semaglutide and from 5 to 15 mg for tirzepatide